Sort
85,873 grants matching “alzheimers”
Defining native proteoform landscape for amyloid-beta in Alzheimers disease
$2,909,025Neil L Kelleher · Northwestern University · RF1 · FY2019 · AG
Proteostasis in Aging and Neurodegenerative Disease
$2,907,560Richard I. Morimoto · Northwestern University · P01 · FY2021 · AG
NBER Coordinating Center on the Economics of AD/ADRD Prevention, Treatment, and Care.
$2,906,646Kathleen McGarry · National Bureau Of Economic Research · U54 · FY2025 · AG
Axonal transport of endo-lysosomal organelles and presynaptic cargoes in the maintenance of axon cellular homeostasis and synaptic function
$2,906,549Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Mild Cognitive Impairment: A Prospective Community Study
$2,906,516Mary Ganguli · University Of Pittsburgh At Pittsburgh · R37 · FY2022 · AG
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
$2,906,437Leah Helane Rubin · Johns Hopkins University · RF1 · FY2023 · MH
Integration of Socio-Spatial Data for Neighborhoods with Multi-omic profiles to Identify and Mitigate Factors Affecting Risk of ALzheimer's Disease
$2,906,000Gladys E. Maestre · University Of Texas Rio Grande Valley · DP1 · FY2020 · AG
Duke/UNC Alzheimer's Disease Research Center
$2,904,608Heather E. Whitson · Duke University · P30 · FY2024 · AG
I3C DECADE: Disparities and Equity in Childhood Cardiovascular Exposures and Alzheimer's Dementia
$2,904,184Lydia Bazzano · Tulane University Of Louisiana · R01 · FY2025 · AG
Brain atrophy, cognitive impairment, and Alzheimer's in a low CVD-risk population
$2,902,118Hillard S Kaplan · Chapman University · RF1 · FY2018 · AG
Age-related metabolic alterations in amyloid processing in Alzheimer's disease
$2,900,360Gregory J Brewer · University Of California-Irvine · RF1 · FY2018 · AG
Center for Integrative Studies of Aging
$2,900,000Buck Institute For Age Research · C06 · FY2004 · RR
Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans
$2,899,817Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · AG
DIAN Clinical Core
$2,898,966Randall J Bateman · Washington University · UF1 · FY2014 · AG
Natives Engaged in Alzheimer's Research
$2,898,840Sterling M McPherson · Washington State University · P01 · FY2024 · AG
Comprehensive diagnosis of Alzheimer's disease by detection of misfolded oligomers in biological fluids
$2,897,592Claudio Soto · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2019 · AG
Multiple Ascending Dose clinical trial of PTI-125, a novel AD therapeutic candidate
$2,896,561Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2019 · AG
Solid oral dosage form and chronic tox for PTI-125
$2,896,320Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2018 · AG
Development And Regulation Of The Gonadotropin Releasing Hormone System
$2,896,223Susan Wray · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Massachusetts Alzheimer's Disease Research Center
$2,895,590Bradley T Hyman · Massachusetts General Hospital · P50 · FY2017 · AG
Covert Cerebrovascular Disease Detected by Artificial Intelligence (C2D2AI): A Platform for Pragmatic Evidence Generation for Stroke and Dementia Prevention
$2,894,758David M Kent · Tufts Medical Center · RF1 · FY2023 · NS
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
$2,894,445Aditi Gupta · University Of Kansas Medical Center · R33 · FY2023 · AG
Peripheral Control of Brain Proteostasis in Aging and Alzheimer Disease
$2,894,095Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2017 · AG
Basal Ganglia in Health and Disease
$2,893,353Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Indiana Alzheimer's Disease Research Center
$2,892,673Andrew J Saykin · Indiana University Indianapolis · P30 · FY2025 · AG